Lymphatic biodistribution of polylactide nanoparticles

Molecular Imaging

Volumn 9, Issue 3, 2010, Pages 153-162

  Chaney, Eric J ^a   Tang, Li ^a   Tong, Rong ^a   Cheng, Jianjun ^a   Boppart, Stephen A ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIODISTRIBUTIONS; CONTROLLED SIZE; EX-VIVO; FLUORESCENCE IMAGING; METASTATIC CANCERS; NANOPARTICLE BIODISTRIBUTION; NANOPRECIPITATION; NUDE MICE; OPTICAL CONTRAST; POLY LACTIDE; SURFACE FEATURE; TUMOR METASTASIS; WHOLE-BODY;

CONTROLLED DRUG DELIVERY; FLUORESCENCE; RING OPENING POLYMERIZATION; ZINC COMPOUNDS;

NANOPARTICLES;

CARBOCYANINE; CYANINE DYE 5; DRUG CARRIER; FLUORESCENT DYE; NANOPARTICLE; POLYESTER; POLYLACTIDE;

ANIMAL; ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG DELIVERY SYSTEM; HISTOLOGY; HUMAN; LYMPHATIC SYSTEM; METABOLISM; METASTASIS; METHODOLOGY; MOUSE; NEOPLASM; NUDE MOUSE; PATHOLOGY; TISSUE DISTRIBUTION;

ANIMALS; CARBOCYANINES; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FLUORESCENT DYES; HUMANS; LYMPHATIC SYSTEM; MICE; MICE, NUDE; MOLECULAR STRUCTURE; NANOPARTICLES; NEOPLASM METASTASIS; NEOPLASMS; POLYESTERS; TISSUE DISTRIBUTION;

EID: 77953493541     PISSN: 15353508     EISSN: None     Source Type: Journal    
DOI: 10.2310/7290.2010.00012     Document Type: Article

References (51)

1. Witte MH, Way DL, Witte CL, Bernas M. Lymphagiogenesis: mechanisms, significance and clinical implications. EXS 1997; 79: 65-112.
2. Liotta LA, Steeg PS, Stetler-Stevenson WG. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 1991; 64: 327-36.
3. Weiss L, Schmidschonbein GW. Biomechanical interactions of cancer cells with the microvasculature during metastasis. Cell Biophys 1989; 14: 187-215.
4. Pepper MS, Tille JC, Nisato R, Skobe M. Lymphangiogenesis and tumor metastasis. Cell Tissue Res 2003; 314: 167-77.
5. de Boer M, van Deurzen CHM, van Dijck J, et al. Micrometastases or isolated tumor cells and the outcome of breast cancer. N Engl J Med 2009; 13: 653-63.
6. Elkin MV, Vlodavsky I. Tail vein assay of cancer metastasis. Curr Protoc Cell Biol 2001; 19: 2.1-2.7.
7. Fidler IJ, Ellis LM. The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell 1994; 79: 185-8.
8. Hart IR, Fidler IJ. Cancer invasion and metastasis. Q Rev Biol 1980; 55: 121-42.
9. Liotta LA. Tumor invasion and metastases-role of the extracellular matrix: Rhoads Memorial Award lecture. Cancer Res 1986; 46: 1-7.
10. Ruoslahti E. How cancer spreads. Sci Am 1996; 275: 72-7.
11. Kim JH, Kim YS, Park K, et al. Antitumor efficacy of cisplatinloaded glycol chitosan nanoparticles in tumor-bearing mice. J Control Release 2008; 127: 41-9.
12. Lee SW, Chang DH, Shim MS, et al. Ionically fixed polymeric nanoparticles as a novel drug carrier. Pharm Res 2007; 24: 1508-16.
13. Min KH, Park K, Kim YS, et al. Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy. J Control Release 2008; 127: 208-18.
14. Ballou B, Ernst LA, Andreko S, et al. Sentinel lymph node imaging using quantum dots in mouse tumor models. Bioconjug Chem 2007; 18: 389-96.
15. Kim S, Lim YT, Soltesz EG, et al. Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping. Nat Biotechnol 2004; 22: 93-7.
16. Kobayashi H, Hama Y, Koyama Y, et al. Simultaneous multicolor imaging of five different lymphatic basins using quantum dots. Nano Lett 2007; 7: 1711-6.
17. Farokhzad OC, Cheng J, Teply BA, et al. Targeted nanoparticleaptamer bioconjugates for cancer chemotherapy in vivo. Proc Natl Acad Sci U S A 2006; 103: 6315-20.
18. Cheng J, Teply BA, Sherifi I, et al. Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery. Biomaterials 2007; 28: 869-76.
19. Tong R, Cheng J. Ring-opening polymerization-mediated controlled formulation of polylactide-drug nanoparticles. J Am Chem Soc 2009; 131: 4744-54.
20. Tong R, Christian DA, Tang L, et al. Nanopolymeric therapeutics. MRS Bull 2009; 34: 422-31.
21. Tong R, Cheng J. Paclitaxel-initiated, controlled polymerization of lactide for the formulation of polymeric nanoparticulate delivery vehicles. Angew Chem Int Ed Engl 2008; 47: 4830-4.
22. Chamberlain BM, Cheng M, Moore DR, et al. Polymerization of lactide with zinc and magnesium beta-diiminate complexes: stereocontrol and mechanism. J Am Chem Soc 2001; 123: 3229-38.
23. Southwick PL, Ernst LA, Tauriello EW, et al. Cyanine dye labeling reagents-carboxymethylindocyanine succinimidyl esters. Cytometry 1990; 11: 418-30.
24. Taback B, Hashimoto K, Kuo CT, et al. Molecular lymphatic mapping of the sentinel lymph node. Am J Pathol 2002; 161: 1153-61.
25. Derfus AM, Chan WCW, Bhatia SN. Probing the cytotoxicity of semiconductor quantum dots. Nano Lett 2004; 4: 11-8.
26. Kirchner C, Liedl T, Kudera S, et al. Cytotoxicity of colloidal CdSe and CdSe/ZnS nanoparticles. Nano Lett 2005; 5: 331-8.
27. Guimaraes R, Clement O, Bittoun J, et al. MR lymphography with superparamagnetic iron nanoparticles in rats: pathologic basis for contrast enhancement. AJR Am J Roentgenol 1994; 162: 201-7.
28. Mouzer R, Shkarin P, Papademetris X, et al. Dynamic imaging of lymphatic vessels and lymph nodes using a bimodal nanoparticulate contrast agent. Lymphat Res Biol 2007; 5: 151-8.
29. Josephson L, Kircher MF, Mahmood U, et al. Near-infrared fluorescent nanoparticles as combined MR/optical imaging probes. Bioconjug Chem 2002; 13: 554-60.
30. Galanzha EI, Shashkov EV, Tuchin VV, Zharov VP. In vivo multispectral, multiparameter, photoacoustic lymph flow cytometry with natural cell focusing, label-free detection and multicolor nanoparticle probes. Cytometry A 2008; 73: 884-94.
31. Galanzha EI, Kokaska MS, Shashkov EV, et al. In vivo fiber-based multicolor photoacoustic detection and photothermal purging of metastasis in sentinel lymph nodes targeted by nanoparticles. J Biophotonics 2009; 2: 528-39.
32. Allen TM, Cullis PR. Drug delivery systems: entering the mainstream. Science 2004; 303: 1818-22.
33. Kataoka K, Harada A, Nagasaki Y. Block copolymer micelles for drug delivery: design, characterization and biological significance. Adv Drug Deliv Rev 2001; 47: 113-31.
34. Ferrari M. Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer 2005; 5: 161-71.
35. Discher DE, Eisenberg A. Polymer vesicles. Science 2002; 297: 967-73.
36. Gao XH, Cui YY, Levenson RM, et al. In vivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotechnol 2004; 22: 969-76.
37. Lee CC, MacKay JA, Frechet JMJ, Szoka FC. Designing dendrimers for biological applications. Nat Biotechnol 2005; 23: 1517-26.
38. Musumeci T, Ventura CA, Giannone I, et al. PLA/PLGA nanoparticles for sustained release of docetaxel. Int J Pharm 2006; 325: 172-9.
39. Mu L, Feng SS. A novel controlled release formulation for the anticancer drug paclitaxel (Taxol (R)) : PLGA nanoparticles containing vitamin E TPGS. J Control Release 2003; 86: 33-48.
40. Avgoustakis K. Pegylated poly (lactide) and ploy (lactide-co-glycolide) nanoparticles: preparation, properties and possible application in drug delivery. Curr Drug Deliv 2004; 1: 321-33.
41. Galindo-Rodriguez S, Allemann E, Fessi H, Doelker E. Physicochemical parameters associated with nanoparticle formation in the salting-out, emulsification-diffusion, and nanoprecipitation methods. Pharm Res 2004; 21: 1428-39.
42. Liu J, Meisner D, Kwong E, et al. A novel trans-lymphatic drug delivery system: implantable gelatin sponge impregnated with PLGA-paclitaxel microspheres. Biomaterials 2007; 28: 3236-44.
43. Weiss L, Ward PM. Lymphogenous and hematogenous metastasis of Lewis lung carcinoma in the mouse. Int J Cancer 1987; 40: 570-4.
44. Veiseh O, Sun C, Gunn J, et al. Optical and MRI multifunctional nanoprobe for targeting gliomas. Nano Lett 2005; 5: 1003-8.
45. Veiseh O, Sun C, Fang C, et al. Specific targeting of brain tumors with an optical/magnetic resonance imaging nanoprobe across the blood-brain barrier. Cancer Res 2009; 69: 6200-7.
46. Aderem A, Underhill DM. Mechanisms of phagocytosis in macrophages. Annu Rev Immunol 1999; 17: 593-623.
47. Oussoren C, Storm G. Liposomes to target the lymphatics by subcutaneous administration. Adv Drug Deliver Rev 2001; 50: 143-56.
48. Farokhzad OC, Cheng J, Teply BA, et al. Targeted nanoparticleaptamer bioconjugates for cancer chemotherapy in vivo. Proc Natl Acad Sci U S A 2006; 103: 6315-20.
49. Frangioni JV. In vivo near-infrared fluorescence imaging. Curr Opin Chem Biol 2003; 7: 626-34.
50. Cody HS. Sentinel lymph node mapping in breast cancer. Breast Cancer 1999; 6: 13-22.
51. Gipponi M, Bassetti C, Canavese G, et al. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients. J Surg Oncol 2004; 85: 102-11.